M2N Co.,Ltd (KOSDAQ:033310)
2,055.00
-225.00 (-9.87%)
At close: Jan 30, 2026
M2N Co.,Ltd Revenue
M2N Co.,Ltd had revenue of 21.52B KRW in the quarter ending September 30, 2025, a decrease of -2.25%. This brings the company's revenue in the last twelve months to 88.99B, up 0.98% year-over-year. In the year 2024, M2N Co.,Ltd had annual revenue of 91.21B with 18.46% growth.
Revenue (ttm)
88.99B
Revenue Growth
+0.98%
P/S Ratio
0.86
Revenue / Employee
514.38M
Employees
173
Market Cap
76.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 91.21B | 14.21B | 18.46% |
| Dec 31, 2023 | 77.00B | 48.54B | 170.63% |
| Dec 31, 2022 | 28.45B | 808.34M | 2.92% |
| Dec 31, 2021 | 27.64B | -7.48B | -21.30% |
| Dec 31, 2020 | 35.12B | -11.34B | -24.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Creas F&C Co.,Ltd | 484.33B |
| FSN Co., Ltd. | 348.13B |
| APRO Co., Ltd | 209.33B |
| Jeil M&S | 202.36B |
| Icure Pharmaceutical Incorporation | 93.22B |
| HRS Co., Ltd | 79.13B |
| WINPAC | 69.62B |
| HLB Genex | 40.95B |